Review
Version 2
This version is not peer-reviewed
Endogenous anti cancer candidates in GPCR, ER stress, and EMT
Version 1
: Received: 5 July 2020 / Approved: 6 July 2020 / Online: 6 July 2020 (08:30:05 CEST)
Version 2 : Received: 8 October 2020 / Approved: 8 October 2020 / Online: 8 October 2020 (13:06:04 CEST)
Version 2 : Received: 8 October 2020 / Approved: 8 October 2020 / Online: 8 October 2020 (13:06:04 CEST)
How to cite: Gundamaraju, R.; Lu, W.; Eri, R. Endogenous anti cancer candidates in GPCR, ER stress, and EMT. Preprints 2020, 2020070097 Gundamaraju, R.; Lu, W.; Eri, R. Endogenous anti cancer candidates in GPCR, ER stress, and EMT. Preprints 2020, 2020070097
Abstract
The majority of cellular responses to external stimuli are mediated by receptors such as G protein-coupled receptors (GPCRs) and systems including endoplasmic reticulum stress (ER stress). Since GPCR signalling is pivotal in numerous malignancies, they are widely targeted by a number of clinical drugs. Cancer cells often negatively modulate GPCRs in order to survive, proliferate and to disseminate. Similarly, numerous branches of the unfolded protein response (UPR) act as pro-survival mediators and are involved in promoting cancer progression via mechanisms such as epithelial to mesenchymal transition (EMT). However, there are a few proteins among these groups which impede deleterious effects by orchestrating the pro-apoptotic phenomenon and paving a therapeutic pathway. The present review exposes and discusses such critical mechanisms and some of the key processes involved in carcinogenesis.
Keywords
ER stress; GPCR; EMT; cancer progression; migration; cancer
Subject
Medicine and Pharmacology, Immunology and Allergy
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (1)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)
* All users must log in before leaving a comment
Commenter: Rohit Gundamaraju
Commenter's Conflict of Interests: Author